PTSF57 – New Compounds, Psychedelic Business, and Neurogenesis

COMPASS Pathways announces pricing of public offering

Numinus Wellness Q2 2021 Results Highlighted by $17.25 Million Financing, Mindspace...

Op-Ed: Re-evaluating the Results of the Recent Trial of Psilocybin vs...

Bexson Biomedical Granted USPTO Patent On Proprietary Ketamine Formulation

Lobe Sciences Announces Filing of PCT Application

Tryp Therapeutics Announces Q2 2021 Financial Results

Small Pharma Completes Reverse Take-Over Transaction

MINDCURE Shares Update on Strong Financial Position, Near Term Revenue Drivers...

BetterLife Files Patent for Invention of Novel Subcutaneous Implant to Prevent...

Load more